A BMT, or bone marrow transplant, is a procedure that replaces damaged or destroyed bone marrow with healthy blood-forming stem cells. It’s used to treat cancers like leukemia and lymphoma, as well as non-cancerous conditions like aplastic anemia and certain immune deficiencies. The procedure involves wiping out your existing bone marrow with chemotherapy or radiation, then infusing new stem cells that rebuild your blood and immune system from scratch.
How Bone Marrow Transplants Work
Bone marrow is the spongy tissue inside your bones that produces all your blood cells: red cells that carry oxygen, white cells that fight infection, and platelets that help with clotting. When disease damages this factory, or when aggressive cancer treatment destroys it, a transplant provides a fresh supply of stem cells to restart blood cell production.
The process has three main phases. First comes conditioning, a preparative phase where you receive high-dose chemotherapy, radiation, or both. This serves multiple purposes: it destroys the diseased marrow, suppresses your immune system enough to accept new cells, and clears space in the bone marrow for incoming stem cells. Conditioning typically lasts several days and is the most physically demanding part of the process.
Next comes the infusion itself, which is surprisingly straightforward. The stem cells are delivered through an IV line, similar to a blood transfusion. Those cells then travel through your bloodstream and find their way into your bone marrow, where they begin producing new blood cells. This settling-in process is called engraftment.
Types of Transplant
There are two main categories, and which one you receive depends on the disease being treated, your age, and whether a suitable donor exists.
- Autologous transplant: Your own stem cells are collected and frozen before conditioning, then infused back into you afterward. This is readily available since no donor search is needed, but carries a risk that the collected cells could contain residual cancer cells.
- Allogeneic transplant: Stem cells come from a donor, either a matched sibling or an unrelated volunteer. The graft is free of your cancer cells, and the donor’s immune cells can actually attack any remaining cancer, a beneficial effect known as graft-versus-malignancy. The tradeoff is a higher risk of complications, since the donor’s immune cells can also attack healthy tissue.
Autologous transplants are more common for conditions like multiple myeloma and certain lymphomas. Allogeneic transplants are used predominantly for leukemias and myelodysplastic syndromes, where the immune effect from donor cells is especially valuable.
Where the Stem Cells Come From
Despite the name “bone marrow transplant,” stem cells can actually be collected from three sources. Peripheral blood is now the most common: the donor receives medication for several days that pushes stem cells out of the marrow and into the bloodstream, where they’re filtered out through a process similar to donating blood. Bone marrow harvest, the traditional method, involves drawing marrow directly from the hip bone under anesthesia. The third option is umbilical cord blood, collected after a baby is born. Cord blood is useful when no matched adult donor is available, though platelet recovery is significantly slower compared to other sources.
Donor Matching
For allogeneic transplants, finding a compatible donor is critical. Compatibility is determined by a set of proteins on your cells called human leukocyte antigens, or HLA markers. For unrelated donors, the standard is an 8 out of 8 match across four specific HLA markers. This level of matching improves overall survival and reduces the risk of life-threatening complications. When a perfect match isn’t available, a 7 out of 8 match can be considered, though risks increase.
Siblings have roughly a 25% chance of being a full match. For matched siblings, a 6 out of 6 match at three key markers is the baseline requirement. When no family match exists, registries like the National Marrow Donor Program search millions of volunteer donors worldwide.
Conditions Treated With BMT
The range of diseases treated by bone marrow transplant is broader than most people expect. On the cancer side, it’s a standard treatment for acute leukemia, multiple myeloma, Hodgkin’s and non-Hodgkin’s lymphoma, myelodysplastic syndromes, and neuroblastoma. For non-cancerous conditions, it can treat aplastic anemia, bone marrow failure syndromes, severe immune deficiencies, inherited metabolic disorders, and blood disorders like sickle cell disease and thalassemia.
Graft-Versus-Host Disease
The most significant complication of allogeneic transplants is graft-versus-host disease, or GVHD. This happens when the donor’s immune cells recognize your body’s tissues as foreign and attack them. Roughly 35% to 50% of allogeneic transplant recipients develop a meaningful form of acute GVHD, typically within the first 100 days. The skin, liver, and digestive tract are the most common targets, causing rashes, jaundice, or severe diarrhea.
The risk varies with how closely the donor matches. With an identical sibling donor, the rate of serious GVHD is about 20%. With a fully matched unrelated donor, it rises to around 30%, and with one or two mismatches, it reaches 40%. About half of patients who develop acute GVHD will go on to develop chronic GVHD, a longer-lasting condition that can resemble autoimmune disorders, affecting the skin, eyes, mouth, and other organs.
Reduced-Intensity Transplants
Traditional full-intensity conditioning is extremely taxing on the body, which historically limited transplants to younger, healthier patients. Reduced-intensity conditioning, sometimes called a “mini-transplant,” uses lower doses of chemotherapy and radiation. This approach still suppresses the immune system enough for donor cells to engraft, but relies more heavily on the donor immune cells to fight the disease over time rather than destroying it all upfront.
Reduced-intensity regimens have expanded transplant eligibility to patients up to age 70 and to those with other health conditions that would make full-intensity conditioning too dangerous. Multiple studies have shown that for patients between 35 and 60 with certain types of leukemia, outcomes with reduced-intensity conditioning are comparable to full-intensity regimens.
Recovery and Engraftment
After the stem cell infusion, there’s a waiting period while the new cells establish themselves. Blood counts typically begin recovering 8 to 14 days after transplant. Your neutrophil count, the key marker of immune recovery, should reach a functional level by 30 days. Platelet recovery takes longer: you may need platelet transfusions for three to six weeks or more.
During this vulnerable window, your immune system is essentially nonexistent. Most patients remain hospitalized or near the transplant center for close monitoring. Infections are the primary concern, since even a mild virus can become life-threatening without functioning white blood cells.
Life After Transplant
The first 100 days after transplant are considered the highest-risk period. During this time, you’ll follow strict precautions to avoid infection. This includes avoiding crowds and contact with anyone who’s sick, wearing a mask in public, and frequent hand washing. At home, you’ll need a separate room and bathroom, limited visitors, and a caregiver to help keep the environment clean.
Diet restrictions are significant. Raw or undercooked meat, unpasteurized dairy, unwashed fruits and vegetables, and unpackaged baked goods are all off-limits. Only treated water, meaning filtered or boiled, is safe to drink. These precautions exist because your rebuilt immune system can’t yet handle the bacteria and fungi that a healthy person’s body handles without issue.
Skin care matters too. Daily showers with mild soap, careful skin hydration, and strict sun protection with daily sunscreen become part of your routine. Your new skin cells are especially sensitive to UV damage, and some medications used to prevent GVHD increase sun sensitivity further. Over months, restrictions gradually ease as your immune system matures. Full immune recovery can take a year or longer, and some patients need to be re-vaccinated for childhood diseases since their previous immunity is wiped out by the conditioning process.